Paul O’Donohoe - senior director of eCOA Product and Science at Medidata, a Dassault Systèmes company, explains how decentralised clinical trials came to be during the Covid-19 pandemic.
Mike Abbadessa, VP SME head of Medical Affairs at Within3, explores the benefits of pharma going virtual and whether the industry is prepared to do so.
Ian Bolland is joined by Martin Gouldstone and Ray Valencia from Sensyne Health to explain more about the use of synthetic control arms, clinical trial transformation, speeding up the process and its SENSIGHT platform – which works within the NHS.
Liz Ashall-Payne, founding CEO of digital health consultancy ORCHA assesses the pharma's potential for digital apps and what the industry needs to bear in mind.
Joe Corrigan, head of Intelligent Healthcare, Cambridge Consultants part of Capgemini Invent, looks at how the medical and technology industries are colliding.
Andrew Dunbar, general manager for EMEA at global digital consultancy, Appnovation, explores the core principles of data analytics and how pharma firms can benefit from this data revolution.
EPM speaks to technology company Lifebit about its collaboration with pharmaceutical organisation Boehringer to report on infectious disease outbreaks.
Brian Flatley, vice president of Consulting Services at S3 Connected Health looks at the digital health landscape and what its adoption means within pharma.
